Guidelines for the management of type 2 diabetes: is ADA and EASD consensus more clinically relevant than the IDF recommendations?

Diabetes Research and Clinical Practice
Leszek Czupryniak

Abstract

Recently, American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) as well as International Diabetes Federation (IDF) have all issued their recommendations on the management of type 2 diabetes. Despite the same objectives, these guidelines are substantially different in terms of target values of glucose control, strategies for drug choice etc. ADA/EASD guidelines offer practical algorithm to help initiate and modify pharmacological therapy for diabetes, with detailed descriptions of treatment options. IDF document, however, concentrates on the role of postprandial hyperglycemia and calls for lower HbA1c target value of 6.5% as opposed to ADA/EASD guidelines advocating value of 7%. Careful analysis of the guidelines contents suggests that ADA/EASD consensus might be more useful in everyday clinical practice than IDF recommendations, which do not offer a particular treatment algorithm.

References

Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
May 27, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Antonio CerielloUNKNOWN Guideline Development Group
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Dec 20, 2008·Primary Care Diabetes·Mariëlle J P van AvendonkGuy E H M Rutten

❮ Previous
Next ❯

Citations

Jun 28, 2005·Clinical and Experimental Nephrology·Ralf SchielGünter Stein
May 8, 2010·Advances in Therapy·Edith M HeintjesRon M C Herings
May 14, 2008·Journal of Endocrinological Investigation·D PitoccoR Gentilella
Oct 16, 2015·Current Diabetes Reports·Shrikant TamhaneVictor M Montori
Aug 24, 2012·Postgraduate Medicine·Priscilla Hollander, Craig Spellman
Dec 19, 2013·PloS One·Ulrich SieringEdmund A Neugebauer
Dec 6, 2005·The Psychiatric Clinics of North America·Stephen J Bartels, Robert E Drake
Feb 14, 2019·Revista da Associação Médica Brasileira·Andrei C Sposito, Carlos Serrano
Feb 16, 2010·Diabetes, Obesity & Metabolism·Ken Fujioka
Jul 21, 2010·International Journal of Clinical Practice·R KadiyalaO E Okosieme
Nov 3, 2010·The Australian Journal of Rural Health·Prasuna ReddyJames A Dunbar
Oct 18, 2016·Eating and Weight Disorders : EWD·Reihaneh PirjaniMahboubeh Hemmatabadi
Nov 26, 2015·Clinical Pharmacokinetics·Lisbeth V JacobsenSteen H Ingwersen
Jul 25, 2009·Pharmacy World & Science : PWS·Bob W van Roozendaal, Ines Krass
Feb 6, 2017·Nature Reviews. Endocrinology·Philip Home
Feb 26, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Jeremy DalePaul Sutcliffe
May 12, 2016·Archives of Toxicology·Christos V RizosMoses S Elisaf
Sep 10, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisR Rizzoli
Jun 22, 2011·Wiener klinische Wochenschrift·Maria FlammAndreas C Sönnichsen
Oct 9, 2013·Journal of General Internal Medicine·Sze Lin YoongAllison Boyes
Dec 10, 2014·Endocrine·Marina George Kudiyirickal, Joseph M Pappachan
Oct 19, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Christian Weber
Jun 28, 2018·Acta Diabetologica·A M Castellano-GuerreroM A Martínez-Brocca
Feb 9, 2012·Current Diabetes Reports·Hsiu-Yueh SuUNKNOWN Task Force for Development of Transcultural Algorithms in Nutrition and Diabetes
Jul 6, 2018·Current Diabetes Reports·Unjali P GujralK M Venkat Narayan
Jul 23, 2013·Indian Journal of Endocrinology and Metabolism·Sanjay KalraK M Prasanna Kumar
Apr 25, 2016·Annals of Global Health·Hernando Vargas-Uricoechea, Luz Ángela Casas-Figueroa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.